Showing posts with label retina. Show all posts
Showing posts with label retina. Show all posts

Saturday, November 12, 2016

Lighting up the Promise of Retinal Gene Therapy

NIH: The retina, like this one from a mouse that is flattened out and captured in a beautiful image, is a thin tissue that lines the back of the eye. Although only about the size of a postage stamp, the retina contains more than 100 distinct cell types that are organized into multiple information-processing layers. These layers work together to absorb light and translate it into electrical signals that stream via the optic nerve to the brain. In people with inherited disorders in which the retina degenerates, an altered gene somewhere within this nexus of cells progressively robs them of their sight.

Zika Virus Can Cause Severe Damage to Retina in Infants

JAMA: In a study published online by JAMA Ophthalmology, Rubens Belfort Jr., M.D., Ph.D., of the Federal University of Sao Paulo, Brazil, and colleagues examined the affected retinal layers in infants with congenital Zika syndrome and associated retinal abnormalities using optical coherence tomography (OCT). The study included 8 infants (age range, 3-5.1 months) with congenital Zika syndrome (CZS), the term created for a variety of anomalies associated with intrauterine Zika virus infection. Optical coherence tomographic images (a noninvasive diagnostic imaging tool that provides cross-sectional retinal images) were obtained in the affected eyes of 7 infants with CZS who had undergone previous ophthalmologic examinations on March 17, 2016, and in 1 infant on January 1, 2016. An IgM antibody-capture enzyme-linked immunosorbent assay for Zika virus was performed on the cerebrospinal fluid samples of 7 of the 8 infants, and other congenital infections were ruled out.

Sunday, November 6, 2016

Artificial retinas : promising leads towards clearer vision

CNRS: A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear. By comparing in rodents the activity of the visual cortex generated artificially by implants against that produced by “natural sight”, scientists from CNRS, CEA, Inserm, AP-HM and Aix-Marseille Université identified two factors that limit the resolution of prostheses. Based on these findings, they were able to improve the precision of prosthetic activation. These multidisciplinary efforts, published on 23 August 2016 in eLife, thus open the way towards further advances in retinal prostheses that will enhance the quality of life of implanted patients.

Monday, February 25, 2013

Age-related macular degeneration (AMD) Overview

Source: Plos Medicine. 2013.

The third leading global cause of blindness (after cataracts and glaucoma) is age-related macular degeneration (AMD).

This group of conditions is characterized by lesions in the macular (central) region of the retina, the tissue at the back of the eye that converts light into electrical messages and sends them to the brain.

AMD, which affects older people, destroys the sharp central vision that is needed for reading or driving, leaving only dim, blurred images or a black hole at the center of vision.

AMD can be diagnosed by examining digital photographs of the retina or by examining the retina directly using a special magnifying lens (slit lamp biomicroscopy).

There is no cure for AMD, although injections into the eye of certain drugs, such as bevacizumab, that block the activity of vascular endothelial growth factor can slow the rate of vision loss caused by some forms of AMD.